AKT1 and breast carcinoma: Our results suggested that MPSE targets survival pathways in irradiated cancer cells possibly by suppressing phosphorylated ERK1/2, AKT, and JNK, which might be associated with the enhanced radiosensitivity of breast cancer cells by MPSE.